Puberty, Precocious Clinical Trial
Official title:
Effect of a GnRH Injection on Ghrelin Concentrations in Girls With Suspected Precocious Puberty
The purposes of the study is to investigate whether circulating levels of ghrelin decreases after an iv injection of GnRH in girls with suspected central premature puberty and to investigate the effects of different post sampling handling on the preservation of acylated ghrelin.
Patients with clinically suspected central premature puberty undergo a GnRH stimulation test
to have an appropriate diagnosis. 20 such girls will be recruited to this study and a
modified GnRH stimulation test will be done. The modification includes prolonged blood
sampling time (0, 30, 60, 90, 120, and 150 min after the GnRH injection instead of the usual
0, 30, 60, and 90 min). The girls will also be investigated twice. In randomised order they
will be given either GnRH or placebo (isotone saline), on different days. One week to one
month will separate the different investigation days.
The proteinase inhibitor 4-(2-aminoethyl) benzene-sulfonyl fluoride hydrochlorid (AEBSF) will
be added to some of the blood tubes, and hydrochloric acid will be added to some of the
plasma. All plasma samples will be frozen and all analyses will be done at the same time.
Acylated ghrelin will be analyzed by Millipore's specific ELISA kit and deacylated ghrelin
will be analyzed by Cayman's specific ELISA kit.
Anthropometric data as well as pubertal state will be collected. P-glucose, S-insulin,
S-follicle stimulating hormone (FSH), S-luteinizing hormone (LH), and S-estradiol will also
be analyzed.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05957991 -
Danish Precocious Puberty Study - DAPP Study A National Cohort Study on Incidence and Etiologies for Precocious Puberty
|
||
| Completed |
NCT04012632 -
Kisspeptin/GPR54 Pathway and Early Puberty
|
||
| Completed |
NCT00094328 -
Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis]
|
Phase 2 | |
| Recruiting |
NCT06083415 -
Early Breast Growth in Girls Aged 6 to 8 Years in the Current Environmental Context
|
N/A | |
| Not yet recruiting |
NCT06263868 -
First Observatory of Precocious Puberty.
|
||
| Completed |
NCT00635817 -
A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty
|
Phase 3 | |
| Completed |
NCT00278915 -
Faslodex in McCune-Albright Syndrome
|
Phase 2 | |
| Completed |
NCT00494169 -
Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders
|
||
| Completed |
NCT00660010 -
Study of Lupron Depot In The Treatment of Central Precocious Puberty
|
Phase 3 | |
| Recruiting |
NCT04884620 -
The 3rd COPENHAGEN Puberty Study
|
||
| Active, not recruiting |
NCT03628937 -
The Effect of Decaffeinated Green Tea Polyphenol Intake on the Risk of Precocious Puberty Among Obese Girls
|
N/A | |
| Enrolling by invitation |
NCT02790112 -
Long-term Outcome of GnRH Analogues Treatment of Children With Idiopathic Central Precocious Puberty
|
N/A |